Firmenbeschreibung
Amgen Inc. zählt weltweit zu den führenden Biotech-Unternehmen. Amgen entwickelt, produziert und vertreibt biopharmazeutische Produkte, die mit Hilfe rekombinanter DNA-Technologien hergestellt werden. Die Forschungsschwerpunkte sind dabei die Hämatologie (Wissenschaft der Blutkrankheiten), Onkologie (Krebsforschung), Nephrologie (Wissenschaft der Nierenkrankheiten), Rheumatologie, Diabetes, Endokrinologie (Lehre der inneren Sekretionsdrüsen), Neurologie und Zelltherapie.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | Freefloat (76.2%),BlackRock, Inc. (9.4%),The Vanguard Group, Inc. (8.7%),State Street Corp. (5.7%) |
sharesOutstanding: | 534326594.0000 |
ceo: | Robert Bradway |
board: | Peter H. Griffith, Annalisa Pizzarello, Anton Rabushka, Arleen Paulino, Darryl Sleep, David A. Piacquad, David M. Reese, Esteban Santos, Gilles Marrache, Ian Thompson, Jean-Charles Soria, Jerry Murry, Jonathan Graham, Judy Gawlik Brown, Lori Johnston, Mark J. Taisey, Mike Zahigian, Murdo Gordon, Nancy Grygiel, Rachna Khosla, Raymond Deshaies, Rob Lenz, Susan Sweeney, Victoria H. Blatter |
supervisoryBoard: | Robert A. Bradway, Amy E. Miles, Brian J. Druker, Charles M. Holley Jr., Ellen J. Kullman, Greg C. Garland, Michael V. Drake, R. Sanders Williams, Robert A. Eckert, Ronald D. Sugar, S. Omar Ishrak, Tyler Jacks, Wanda M. Austin |
countryID: | 20 |
freeFloat: | 76.2000 |
faceValue: | 0.0001 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Medizintechnische Produkte |
industryName: | Gesundheitswesen |
subsectorName: | Hochentwickelte medizinische Geräte |
country: | USA |
countryName: | USA |
Kontakt
phone: | +1-805-447-1060 |
irWebSite: | is.gd/wUZ7Wp |
Adresse
street: | One Amgen Center Drive |
city: | Thousand Oaks, CA 91320-1799, USA |
phone: | +1-805-447-1000 |
fax: | +1-805-447-1010 |
webSite: | www.amgen.com |
email: | investor.relations@amgen.com |
Finanzen (kurz)
year: | 2020 | cash: | 6266.0000 |
balanceSheetTotal: | 62948.0000 | liabilities: | 53539.0000 |
totalShareholdersEquity: | 9409.0000 | sales: | 25424.0000 |
bankLoans: | 9139.0000 | investment: | 256.0000 |
incomeBeforeTaxes: | 8133.0000 | netIncome: | 7264.0000 |
cashFlow: | 229.0000 | employees: | 24300 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2021 | cash: | 7989.0000 |
balanceSheetTotal: | 61165.0000 | liabilities: | 54465.0000 |
totalShareholdersEquity: | 6700.0000 | sales: | 25979.0000 |
bankLoans: | 7639.0000 | investment: | 259.0000 |
incomeBeforeTaxes: | 6701.0000 | netIncome: | 5893.0000 |
cashFlow: | 1723.0000 | employees: | 24200 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2022 | cash: | 7629.0000 |
balanceSheetTotal: | 65121.0000 | liabilities: | 61460.0000 |
totalShareholdersEquity: | 3661.0000 | sales: | 26323.0000 |
incomeBeforeTaxes: | 7346.0000 | netIncome: | 6552.0000 |
cashFlow: | -360.0000 | currencyID: | 4 |
units: | 1000000 | currency: | USD |
Finanzen (kurz)
year: | 2020 |
cash: | 6266.0000 |
balanceSheetTotal: | 62948.0000 |
liabilities: | 53539.0000 |
totalShareholdersEquity: | 9409.0000 |
sales: | 25424.0000 |
bankLoans: | 9139.0000 |
investment: | 256.0000 |
incomeBeforeTaxes: | 8133.0000 |
netIncome: | 7264.0000 |
cashFlow: | 229.0000 |
employees: | 24300 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2021 |
cash: | 7989.0000 |
balanceSheetTotal: | 61165.0000 |
liabilities: | 54465.0000 |
totalShareholdersEquity: | 6700.0000 |
sales: | 25979.0000 |
bankLoans: | 7639.0000 |
investment: | 259.0000 |
incomeBeforeTaxes: | 6701.0000 |
netIncome: | 5893.0000 |
cashFlow: | 1723.0000 |
employees: | 24200 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2022 |
cash: | 7629.0000 |
balanceSheetTotal: | 65121.0000 |
liabilities: | 61460.0000 |
totalShareholdersEquity: | 3661.0000 |
sales: | 26323.0000 |
incomeBeforeTaxes: | 7346.0000 |
netIncome: | 6552.0000 |
cashFlow: | -360.0000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2021 | units: | 1000000 |
balanceSheetTotal: | 61165.0000 | cash: | 7989.0000 |
currentAssets: | 19385.0000 | fixedAssets: | 41780.0000 |
liabilities: | 12184.0000 | totalLiabilitiesEquity: | 61165.0000 |
provisions: | 10731.0000 | totalShareholdersEquity: | 6700.0000 |
employees: | 24200 | property: | 5184.0000 |
intangibleAssets: | 15182.0000 | inventories: | 4086.0000 |
accountsReceivable: | 4895.0000 | currentSecurities: | 48.0000 |
accountsPayable: | 1366.0000 | liabilitiesTotal: | 54465.0000 |
longTermDebt: | 33222.0000 | shortTermDebt: | 87.0000 |
sales: | 25979.0000 | netIncome: | 5893.0000 |
operatingResult: | 7639.0000 | ebitda: | 7639.0000 |
incomeInterest: | -1197.0000 | investments: | 4819.0000 |
incomeTaxes: | 808.0000 | costGoodsSold: | 6454.0000 |
grossProfit: | 19525.0000 | revenuePerEmployee: | 1073512.3967 |
cashFlow: | 9261.0000 | cashFlowInvesting: | 733.0000 |
cashFlowFinancing: | -8271.0000 | cashFlowTotal: | 1723.0000 |
accountingStandard: | US GAAP | equityRatio: | 10.9540 |
debtEquityRatio: | 812.9104 | liquidityI: | 65.9636 |
liquidityII: | 106.1392 | netMargin: | 22.6837 |
grossMargin: | 75.1569 | cashFlowMargin: | 35.6480 |
ebitMargin: | 29.4045 | ebitdaMargin: | 29.4045 |
preTaxROE: | 100.0149 | preTaxROA: | 10.9556 |
roe: | 87.9552 | roa: | 9.6346 |
netIncomeGrowth: | -18.8739 | revenuesGrowth: | 2.1830 |
taxExpenseRate: | 12.0579 | equityTurnover: | 3.8775 |
epsBasic: | 10.3400 | epsDiluted: | 10.2800 |
epsBasicGrowth: | -16.6129 | incomeBeforeTaxes: | 6701.0000 |
priceEarningsRatioCompany: | 21.7573 | priceCashFlowRatio: | 13.5315 |
dividendYield: | 3.2093 | bookValuePerShare: | 12.0281 |
marketCap: | 125314897368.9000 | earningsYield: | 4.5962 |
pegRatio: | -1.3097 | cashFlowPerShare: | 16.6257 |
priceBookValueRatio: | 18.7037 | dividendsPerShare: | 7.2200 |
priceEarningsRatio: | 21.2650 | netEarningsPerShare: | 10.5793 |
currency: | USD |
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 65121.0000 | cash: | 7629.0000 |
currentAssets: | 22186.0000 | fixedAssets: | 42935.0000 |
liabilities: | 15687.0000 | totalLiabilitiesEquity: | 65121.0000 |
totalShareholdersEquity: | 3661.0000 | property: | 5427.0000 |
intangibleAssets: | 16080.0000 | inventories: | 4930.0000 |
accountsReceivable: | 5563.0000 | accountsPayable: | 1572.0000 |
liabilitiesTotal: | 61460.0000 | longTermDebt: | 37354.0000 |
shortTermDebt: | 1591.0000 | sales: | 26323.0000 |
netIncome: | 6552.0000 | operatingResult: | 9566.0000 |
incomeInterest: | -1406.0000 | investments: | 4434.0000 |
incomeTaxes: | 794.0000 | costGoodsSold: | 6406.0000 |
grossProfit: | 19917.0000 | cashFlow: | 9721.0000 |
cashFlowInvesting: | -6044.0000 | cashFlowFinancing: | -4037.0000 |
cashFlowTotal: | -360.0000 | accountingStandard: | US GAAP |
equityRatio: | 5.6218 | debtEquityRatio: | 1678.7763 |
liquidityI: | 48.6326 | liquidityII: | 84.0951 |
netMargin: | 24.8908 | grossMargin: | 75.6639 |
cashFlowMargin: | 36.9297 | ebitMargin: | 36.3408 |
ebitdaMargin: | 0.0000 | preTaxROE: | 200.6556 |
preTaxROA: | 11.2805 | roe: | 178.9675 |
roa: | 10.0613 | netIncomeGrowth: | 11.1828 |
revenuesGrowth: | 1.3241 | taxExpenseRate: | 10.8086 |
equityTurnover: | 7.1901 | epsBasic: | 12.1800 |
epsDiluted: | 12.1100 | epsBasicGrowth: | 17.7950 |
incomeBeforeTaxes: | 7346.0000 | priceEarningsRatioCompany: | 21.5632 |
priceCashFlowRatio: | 14.4269 | dividendYield: | 3.0270 |
bookValuePerShare: | 6.8561 | marketCap: | 140243519148.3200 |
earningsYield: | 4.6375 | pegRatio: | 1.2118 |
cashFlowPerShare: | 18.2049 | priceBookValueRatio: | 38.3074 |
dividendsPerShare: | 7.9500 | priceEarningsRatio: | 21.4047 |
netEarningsPerShare: | 12.2702 | currency: | USD |
year: | 2023 | priceEarningsRatioCompany: | 17.8103 |
priceCashFlowRatio: | 11.9160 | dividendYield: | 3.6648 |
bookValuePerShare: | 6.8561 | marketCap: | 115911468036.4200 |
earningsYield: | 5.6147 | pegRatio: | 1.0009 |
cashFlowPerShare: | 18.2049 | netAssetsPerShare: | 6.8561 |
priceBookValueRatio: | 31.6404 | priceEarningsRatio: | 17.6794 |
netEarningsPerShare: | 12.2702 | currency: | USD |
Finanzen (ausführlich)
year: | 2021 |
units: | 1000000 |
balanceSheetTotal: | 61165.0000 |
cash: | 7989.0000 |
currentAssets: | 19385.0000 |
fixedAssets: | 41780.0000 |
liabilities: | 12184.0000 |
totalLiabilitiesEquity: | 61165.0000 |
provisions: | 10731.0000 |
totalShareholdersEquity: | 6700.0000 |
employees: | 24200 |
property: | 5184.0000 |
intangibleAssets: | 15182.0000 |
inventories: | 4086.0000 |
accountsReceivable: | 4895.0000 |
currentSecurities: | 48.0000 |
accountsPayable: | 1366.0000 |
liabilitiesTotal: | 54465.0000 |
longTermDebt: | 33222.0000 |
shortTermDebt: | 87.0000 |
sales: | 25979.0000 |
netIncome: | 5893.0000 |
operatingResult: | 7639.0000 |
ebitda: | 7639.0000 |
incomeInterest: | -1197.0000 |
investments: | 4819.0000 |
incomeTaxes: | 808.0000 |
costGoodsSold: | 6454.0000 |
grossProfit: | 19525.0000 |
revenuePerEmployee: | 1073512.3967 |
cashFlow: | 9261.0000 |
cashFlowInvesting: | 733.0000 |
cashFlowFinancing: | -8271.0000 |
cashFlowTotal: | 1723.0000 |
accountingStandard: | US GAAP |
equityRatio: | 10.9540 |
debtEquityRatio: | 812.9104 |
liquidityI: | 65.9636 |
liquidityII: | 106.1392 |
netMargin: | 22.6837 |
grossMargin: | 75.1569 |
cashFlowMargin: | 35.6480 |
ebitMargin: | 29.4045 |
ebitdaMargin: | 29.4045 |
preTaxROE: | 100.0149 |
preTaxROA: | 10.9556 |
roe: | 87.9552 |
roa: | 9.6346 |
netIncomeGrowth: | -18.8739 |
revenuesGrowth: | 2.1830 |
taxExpenseRate: | 12.0579 |
equityTurnover: | 3.8775 |
epsBasic: | 10.3400 |
epsDiluted: | 10.2800 |
epsBasicGrowth: | -16.6129 |
incomeBeforeTaxes: | 6701.0000 |
priceEarningsRatioCompany: | 21.7573 |
priceCashFlowRatio: | 13.5315 |
dividendYield: | 3.2093 |
bookValuePerShare: | 12.0281 |
marketCap: | 125314897368.9000 |
earningsYield: | 4.5962 |
pegRatio: | -1.3097 |
cashFlowPerShare: | 16.6257 |
priceBookValueRatio: | 18.7037 |
dividendsPerShare: | 7.2200 |
priceEarningsRatio: | 21.2650 |
netEarningsPerShare: | 10.5793 |
currency: | USD |
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 65121.0000 |
cash: | 7629.0000 |
currentAssets: | 22186.0000 |
fixedAssets: | 42935.0000 |
liabilities: | 15687.0000 |
totalLiabilitiesEquity: | 65121.0000 |
totalShareholdersEquity: | 3661.0000 |
property: | 5427.0000 |
intangibleAssets: | 16080.0000 |
inventories: | 4930.0000 |
accountsReceivable: | 5563.0000 |
accountsPayable: | 1572.0000 |
liabilitiesTotal: | 61460.0000 |
longTermDebt: | 37354.0000 |
shortTermDebt: | 1591.0000 |
sales: | 26323.0000 |
netIncome: | 6552.0000 |
operatingResult: | 9566.0000 |
incomeInterest: | -1406.0000 |
investments: | 4434.0000 |
incomeTaxes: | 794.0000 |
costGoodsSold: | 6406.0000 |
grossProfit: | 19917.0000 |
cashFlow: | 9721.0000 |
cashFlowInvesting: | -6044.0000 |
cashFlowFinancing: | -4037.0000 |
cashFlowTotal: | -360.0000 |
accountingStandard: | US GAAP |
equityRatio: | 5.6218 |
debtEquityRatio: | 1678.7763 |
liquidityI: | 48.6326 |
liquidityII: | 84.0951 |
netMargin: | 24.8908 |
grossMargin: | 75.6639 |
cashFlowMargin: | 36.9297 |
ebitMargin: | 36.3408 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 200.6556 |
preTaxROA: | 11.2805 |
roe: | 178.9675 |
roa: | 10.0613 |
netIncomeGrowth: | 11.1828 |
revenuesGrowth: | 1.3241 |
taxExpenseRate: | 10.8086 |
equityTurnover: | 7.1901 |
epsBasic: | 12.1800 |
epsDiluted: | 12.1100 |
epsBasicGrowth: | 17.7950 |
incomeBeforeTaxes: | 7346.0000 |
priceEarningsRatioCompany: | 21.5632 |
priceCashFlowRatio: | 14.4269 |
dividendYield: | 3.0270 |
bookValuePerShare: | 6.8561 |
marketCap: | 140243519148.3200 |
earningsYield: | 4.6375 |
pegRatio: | 1.2118 |
cashFlowPerShare: | 18.2049 |
priceBookValueRatio: | 38.3074 |
dividendsPerShare: | 7.9500 |
priceEarningsRatio: | 21.4047 |
netEarningsPerShare: | 12.2702 |
currency: | USD |
year: | 2023 |
priceEarningsRatioCompany: | 17.8103 |
priceCashFlowRatio: | 11.9160 |
dividendYield: | 3.6648 |
bookValuePerShare: | 6.8561 |
marketCap: | 115911468036.4200 |
earningsYield: | 5.6147 |
pegRatio: | 1.0009 |
cashFlowPerShare: | 18.2049 |
netAssetsPerShare: | 6.8561 |
priceBookValueRatio: | 31.6404 |
priceEarningsRatio: | 17.6794 |
netEarningsPerShare: | 12.2702 |
currency: | USD |